- Poster presentation
- Open access
- Published:
Early magnesium treatment after aneurysmal subarachnoid hemorrhage: an individual patient data meta-analysis
Intensive Care Medicine Experimental volume 3, Article number: A774 (2015)
Introduction
Delayed cerebral ischemia (DCI) is an important cause of poor outcome after aneurysmal subarachnoid hemorrhage (SAH). Trials on magnesium treatment starting < 4 days after symptom onset found no effect on poor outcome or DCI in SAH. Earlier instalment of treatment might be more effective, but individual trials had not enough power for such a sub-analysis.
Objectives
We performed an individual patient data meta-analysis to study whether magnesium is effective when given within different time frames within 24 hours after the SAH.
Methods
Patients were divided into categories according to the delay between symptom onset and start of the study medication: < 6 hours, 6-12 hours, 12-24 hours, > 24 hours. We calculated adjusted risk ratios (aRR) with corresponding 95% confidence intervals (CI) for magnesium versus placebo treatment for poor outcome and DCI.
Results
We included 5 trials totalling 1981 patients, 83 patients started treatment < 6 hours. For poor outcome the aRRs of magnesium treatment for start < 6 hours were 1.44 (95%CI:0.83-2.51); for 6-12 hours 1.03(0.65-1.63), for 12-24 hours 0.84(0.65-1.09) and for >24 hours 1.06(0.87-1.31), and for DCI, < 6 hours 1.76(0.68-4.58), for 6-12 hours 2.09(0.99-4.39), for 12-24 hours 0.80(0.56-1.16) and for > 24 hours 1.08(0.88-1.32).
Conclusions
This meta-analysis suggests no beneficial effect of magnesium treatment on poor outcome or DCI when started early after SAH onset. Although the number of patients was small and a beneficial effect cannot be definitively excluded, we found no justification for a new trial with early magnesium treatment after SAH.
Author information
Authors and Affiliations
Consortia
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
van den Bergh, W., writing groups of MASH-I, IMASH, MASH-II, MASH and FAST-MAG. Early magnesium treatment after aneurysmal subarachnoid hemorrhage: an individual patient data meta-analysis. ICMx 3 (Suppl 1), A774 (2015). https://doi.org/10.1186/2197-425X-3-S1-A774
Published:
DOI: https://doi.org/10.1186/2197-425X-3-S1-A774